ClinicalTrials.gg
CompletedNCT05542823Updated Jan 12, 2026

Effect of Cuff Pressure of Endotracheal Tube on POST

An observational study in Laparoscopic Surgery, Tracheal Intubation Morbidity and Sore-throat, sponsored by Seoul National University Hospital. Completed at 2 sites in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-01-12.

Primary conditionPharyngitis(the registry's first term)UnverifiedIs this wrong?The registry often attaches Pharyngitis to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Seoul National University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
337
Ages
19 Years and older
Sex
All
01

Study summary

The main objective of this study is to evaluate the association between the duration of intraoperative cuff overpressure and the development of postoperative sore throat.

Read the detailed description

For patients undergoing laparoscopic surgery after tracheal intubation, continuous cuff pressure monitoring is performed by connecting a pressure monitor to the cuff of the endotracheal tube. The incidence of postoperative sore throat was evaluated via direct questioning in all patients. This study aimed to investigate the association between the development of postoperative sore throat and the duration of overpressure in the cuff of the endotracheal tube.

02

Conditions studied

  • Laparoscopic Surgery
  • Tracheal Intubation Morbidity
  • Sore-throat

Browse trials for

Keywords

  • Laparoscopic surgery
  • Endotracheal intubation
  • Cuff pressure
  • Sore throat
  • Hoarseness
03

In context

Pharyngitis Unverified

226 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's enrollment of 337 is above the median of 289 across 33 observational studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Compared within Pharyngitis, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients undergoing laparoscopic surgery and endotracheal intubation under general anesthesia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Patients undergoing laparoscopic surgery and endotracheal intubation under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • Patients who already had sore throat and hoarseness before surgery
  • Patients who were expected to have anticipated difficult airway
  • Surgery duration \< 1 hour
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
337 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of postoperative sore throat at 24h postoperatively.

    Incidence of postoperative sore throat (score 1 or more) 0 = no sore throat 1. = mild sore throat (less severe 1 = mild sore throat (less severe than with a cold) 2. = moderate sore throat (as with a cold)2 = moderate sore throat (as with a cold) 3. = severe (more severe than with a cold)3 = severe (more severe than with a cold)

    Time frame: at 24h postoperatively.

Secondary outcomes

  1. Incidence of postoperative sore throat at 1h postoperatively.

    Incidence of postoperative sore throat (score 1 or more) 0 = no sore throat 1. = mild sore throat (less severe 1 = mild sore throat (less severe than with a cold) 2. = moderate sore throat (as with a cold)2 = moderate sore throat (as with a cold) 3. = severe (more severe than with a cold)3 = severe (more severe than with a cold)

    Time frame: at 1h postoperatively

  2. Incidence of postoperative sore throat at 48h postoperatively.

    Incidence of postoperative sore throat (score 1 or more) 0 = no sore throat 1. = mild sore throat (less severe 1 = mild sore throat (less severe than with a cold) 2. = moderate sore throat (as with a cold)2 = moderate sore throat (as with a cold) 3. = severe (more severe than with a cold)3 = severe (more severe than with a cold)

    Time frame: at 48h postoperatively

  3. Incidence of postoperative hoarseness at 1h postoperatively.

    Incidence of postoperative hoarseness (score 1 or more) 0 = no hoarseness 1. = mild hoarseness (noticed by the patient only) 2. = severe hoarseness (noticed by the time of the interview by the personnel) 3. = aphonia (inability to speak)

    Time frame: at 1h postoperatively

  4. Incidence of postoperative hoarseness at 24h postoperatively.

    Incidence of postoperative hoarseness (score 1 or more) 0 = no hoarseness 1. = mild hoarseness (noticed by the patient only) 2. = severe hoarseness (noticed by the time of the interview by the personnel) 3. = aphonia (inability to speak)

    Time frame: at 24h postoperatively.

  5. Incidence of postoperative hoarseness at 48h postoperatively.

    Incidence of postoperative hoarseness (score 1 or more) 0 = no hoarseness 1. = mild hoarseness (noticed by the patient only) 2. = severe hoarseness (noticed by the time of the interview by the personnel) 3. = aphonia (inability to speak)

    Time frame: at 48h postoperatively

07

Study locations

2 sites
  • Seoul national university hospital
    Seoul, Please Select An Option 03080, South Korea
  • Hyun-Kyu Yoon
    Seoul, South Korea
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05542823
Responsible party
Hyun-Kyu Yoon (Clinical assistant professor, Seoul National University Hospital) — Principal investigator
First posted
Sep 16, 2022
Start date
Oct 4, 2022
Primary completion
Aug 7, 2025
Completion
Aug 10, 2025
Last update
Jan 12, 2026

Study contacts

Hyun-Kyu Yoon
principal investigator · Seoul National University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion